These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2462563)

  • 41. Malignant histiocytosis and Letterer-Siwe disease. Neoplasms of T-zone histiocyte with S100 protein.
    Watanabe S; Nakajima T; Shimosato Y; Sato Y; Shimizu K
    Cancer; 1983 Apr; 51(8):1412-24. PubMed ID: 6687444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Malignant histiocytosis: a study on clinicopathological features and cell origin].
    Li PJ
    Zhonghua Bing Li Xue Za Zhi; 1991 Dec; 20(4):250-3. PubMed ID: 1813156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Idiopathic differentiated histiocytosis.
    Daneshbod K; Kissane JM
    Am J Clin Pathol; 1978 Sep; 70(3):381-9. PubMed ID: 309279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peanut agglutinin. A useful marker for histiocytosis X and interdigitating reticulum cells.
    Ree HJ; Kadin ME
    Cancer; 1986 Jan; 57(2):282-7. PubMed ID: 2417675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delineation of four cell types comprising the giant cell tumor of bone. Expression of Ia and monocyte-macrophage lineage antigens.
    Burmester GR; Winchester RJ; Dimitriu-Bona A; Klein M; Steiner G; Sissons HA
    J Clin Invest; 1983 Jun; 71(6):1633-48. PubMed ID: 6575016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Lewis X antigen. A new paraffin section marker for Reed-Sternberg cells.
    Ree HJ; Teplitz C; Khan A
    Cancer; 1991 Mar; 67(5):1338-46. PubMed ID: 1703918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1 (CD68).
    Binder SW; Said JW; Shintaku IP; Pinkus GS
    Am J Clin Pathol; 1992 Jun; 97(6):759-63. PubMed ID: 1317667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.
    Yu H; Gibson JA; Pinkus GS; Hornick JL
    Am J Clin Pathol; 2007 Nov; 128(5):776-82. PubMed ID: 17951199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histiocytes in familial and infection-induced/idiopathic hemophagocytic syndromes may exhibit phenotypic differences.
    Buckley PJ; O'Laughlin S; Komp DM
    Pediatr Pathol; 1992; 12(1):51-66. PubMed ID: 1348582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
    Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
    Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Malignant fibrous histiocytoma tumor cells resemble fibroblasts.
    Wood GS; Beckstead JH; Turner RR; Hendrickson MR; Kempson RL; Warnke RA
    Am J Surg Pathol; 1986 May; 10(5):323-35. PubMed ID: 3010748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Malignant fibrous histiocytoma. A tumor of facultative histiocytes showing mesenchymal differentiation in cultured cell lines.
    Iwasaki H; Isayama T; Ohjimi Y; Kikuchi M; Yoh S; Shinohara N; Yoshitake K; Ishiguro M; Kamada N; Enjoji M
    Cancer; 1992 Jan; 69(2):437-47. PubMed ID: 1309433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histiocytic malignancies. Morphologic, immunologic, and enzymatic heterogeneity.
    Turner RR; Wood GS; Beckstead JH; Colby TV; Horning SJ; Warnke RA
    Am J Surg Pathol; 1984 Jul; 8(7):485-500. PubMed ID: 6204546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matrix vesicles in bone tumors. Ultrastructural analysis and their significance in neoplastic bone formation.
    Yoshida H; Miyazaki S; Yumoto T
    Acta Pathol Jpn; 1991 Aug; 41(8):610-7. PubMed ID: 1661059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.
    Delsol G; Al Saati T; Gatter KC; Gerdes J; Schwarting R; Caveriviere P; Rigal-Huguet F; Robert A; Stein H; Mason DY
    Am J Pathol; 1988 Jan; 130(1):59-70. PubMed ID: 2827494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical comparison of cutaneous histiocytoses and related skin disorders: diagnostic and histogenetic relevance of MS-1 high molecular weight protein expression.
    Goerdt S; Kolde G; Bonsmann G; Hamann K; Czarnetzki B; Andreesen R; Luger T; Sorg C
    J Pathol; 1993 Aug; 170(4):421-7. PubMed ID: 7692027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enzyme histochemical study on bone tumors.
    Yoshida H; Akeho M; Orido T; Yumoto T; Furuse K; Maeyama I; Tanaka T
    Acta Med Okayama; 1982 Dec; 36(6):469-82. PubMed ID: 6297258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunophenotypic and immunoelectron microscopic characterization of major constituent cells in malignant fibrous histiocytoma using human cell lines and their transplanted tumors in immunodeficient mice.
    Takeya M; Yamashiro S; Yoshimura T; Takahashi K
    Lab Invest; 1995 Jun; 72(6):679-88. PubMed ID: 7783426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. True malignant histiocytosis.
    Mongkonsritragoon W; Li CY; Phyliky RL
    Mayo Clin Proc; 1998 Jun; 73(6):520-8. PubMed ID: 9621858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malignant fibrous histiocytoma of bone and osteosarcoma. A comparative light and electron microscopic study.
    Roessner A; Hobik HP; Grundmann E
    Pathol Res Pract; 1979 Aug; 164(4):385-401. PubMed ID: 229475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.